Nurix Therapeutics, Inc.NRIXNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+56.5%
5Y CAGR+15.7%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+56.5%/yr
vs +26.0%/yr prior
5Y CAGR
+15.7%/yr
Recent acceleration
Acceleration
+30.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $246.96M | +124.5% |
| 2024 | $110.00M | +101.4% |
| 2023 | $54.63M | -15.3% |
| 2022 | $64.47M | -19.9% |
| 2021 | $80.51M | -32.5% |
| 2020 | $119.36M | +242.8% |
| 2019 | $34.82M | +36.0% |
| 2018 | $25.59M | - |